2019
DOI: 10.1016/j.micpath.2019.05.021
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in silico approaches of antibiofilm activity of 1-hydroxy-1-norresistomycin against human clinical pathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Additionally, it also exhibited potent cytotoxic activity against cell lines viz. HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) in vitro [108].…”
Section: Polyketidesmentioning
confidence: 99%
“…Additionally, it also exhibited potent cytotoxic activity against cell lines viz. HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) in vitro [108].…”
Section: Polyketidesmentioning
confidence: 99%
“…Moreover, according to the 2017 CDC report, 30-50% antibiotic therapies were inappropriate or unnecessary. Importantly, the number of resistant bacteria has increased in recent years, whilst the advancement in production of new antibiotics is limited [92,99,164,165]. Besides the use antibiotics in medicine, antibiotic resistance may also appear for another reason.…”
Section: Discussionmentioning
confidence: 99%
“…NHP was assessed for its primary antibiofilm activity against E. coli , P. aeruginosa , and S. aureus and was initially confirmed using the UV spectrometric method ( Ramalingam et al., 2019 ). Briefly, the pure colony cultured in the LB broth for 24 h at 37°C and 200 μl (OD 600 nm = 1.0) of the culture was inoculated in a 96-well polystyrene plate with various amounts of NHP (0–200 µg/ml).…”
Section: Methodsmentioning
confidence: 99%